Stockreport

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024 [Yahoo! Finance]

INTEGRATED BIOPHARMA INC  (INBP) 
US:NASDAQ Investor Relations: ibiopharma.com
PDF Revenue for the quarter ended September 30, 2024 was $13.6 million compared to $12.9 million for the quarter ended September 30, 2023, an increase of $0.7 million or ap [Read more]